"Designing Growth Strategies is in our DNA"

Equine Health Market Size, Share & Industry Analysis, By Product (Drug Class, {Anti-Infective, Anti-Inflammatory, Parasiticides, and Others}, Vaccines {Inactivated, Live Attenuated, Recombinant, and Others}, and Supplemental Feed Additives), By Disease Type (West Nile Virus, Equine Rabies, Equine Influenza, Equine Herpes Virus, Potomac Horse Fever, Tetanus, and Others), By Distribution Channel (Veterinary Hospitals And Clinics, Retail Pharmacies and Drug Stores, and Others), and Regional Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI101416

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Statistics: Equine Population, By Key Countries, 2024
    2. Regulatory Scenario, Equine Health, By Key Countries, 2024
    3. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, etc.)
    4. Technology Advances in Equine Health
    5. Impact of Covid-19 on the Market
  5. Global Equine Health Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product
      1. Drug Type
        1. Anti-Infectives
        2. Anti-Inflammatory
        3. Parasiticides
        4. Others
      2. Vaccine Type
        1. Inactivated
        2. Live Attenuated
        3. Recombinant
        4. Others
      3. Supplemental Feed Additives
    2. Market Analysis, Insights and Forecast – By Disease Type
      1. West Nile Virus
      2. Equine Rabies
      3. Equine Influenza
      4. Equine Herpes Virus
      5. Potomac Horse Fever
      6. Tetanus
      7. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Veterinary Hospitals and Clinics
      2. Retail Pharmacies and Drug Stores
      3. Others
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Equine Health Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product
      1. Drug Type
        1. Anti-Infectives
        2. Anti-Inflammatory
        3. Parasiticides
        4. Others
      2. Vaccine Type
        1. Inactivated
        2. Live Attenuated
        3. Recombinant
        4. Others
      3. Supplemental Feed Additives
    2. Market Analysis, Insights and Forecast – By Disease Type
      1. West Nile Virus
      2. Equine Rabies
      3. Equine Influenza
      4. Equine Herpes Virus
      5. Potomac Horse Fever
      6. Tetanus
      7. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Veterinary Hospitals and Clinics
      2. Retail Pharmacies and Drug Stores
      3. Others 
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Equine Health Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product
      1. Drug Type
        1. Anti-Infectives
        2. Anti-Inflammatory
        3. Parasiticides
        4. Others
      2. Vaccine Type
        1. Inactivated
        2. Live Attenuated
        3. Recombinant
        4. Others
      3. Supplemental Feed Additives
    2. Market Analysis, Insights and Forecast – By Disease Type
      1. West Nile Virus
      2. Equine Rabies
      3. Equine Influenza
      4. Equine Herpes Virus
      5. Potomac Horse Fever
      6. Tetanus
      7. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Veterinary Hospitals and Clinics
      2. Retail Pharmacies and Drug Stores
      3. Others 
    4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. U.K.
      2. Germany
      3. France
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Equine Health Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product
      1. Drug Type
        1. Anti-Infectives
        2. Anti-Inflammatory
        3. Parasiticides
        4. Others
      2. Vaccine Type
        1. Inactivated
        2. Live Attenuated
        3. Recombinant
        4. Others
      3. Supplemental Feed Additives
    2. Market Analysis, Insights and Forecast – By Disease Type
      1. West Nile Virus
      2. Equine Rabies
      3. Equine Influenza
      4. Equine Herpes Virus
      5. Potomac Horse Fever
      6. Tetanus
      7. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Veterinary Hospitals and Clinics
      2. Retail Pharmacies and Drug Stores
      3. Others
    4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Equine Health Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product
      1. Drug Type
        1. Anti-Infectives
        2. Anti-Inflammatory
        3. Parasiticides
        4. Others
      2. Vaccine Type
        1. Inactivated
        2. Live Attenuated
        3. Recombinant
        4. Others
      3. Supplemental Feed Additives
    2. Market Analysis, Insights and Forecast – By Disease Type
      1. West Nile Virus
      2. Equine Rabies
      3. Equine Influenza
      4. Equine Herpes Virus
      5. Potomac Horse Fever
      6. Tetanus
      7. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Veterinary Hospitals and Clinics
      2. Retail Pharmacies and Drug Stores
      3. Others
    4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Equine Health Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product
      1. Drug Type
        1. Anti-Infectives
        2. Anti-Inflammatory
        3. Parasiticides
        4. Others
      2. Vaccine Type
        1. Inactivated
        2. Live Attenuated
        3. Recombinant
        4. Others
      3. Supplemental Feed Additives
    2. Market Analysis, Insights and Forecast – By Disease Type
      1. West Nile Virus
      2. Equine Rabies
      3. Equine Influenza
      4. Equine Herpes Virus
      5. Potomac Horse Fever
      6. Tetanus
      7. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Veterinary Hospitals and Clinics
      2. Retail Pharmacies and Drug Stores
      3. Others
    4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. GCC
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2024)
    2. Company Profiles
      1. Zoetis Services LLC
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Ceva
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Elanco
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Boehringer Ingelheim International GmbH
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Vetoquinol
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. Neogen Corporation
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Virbac
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. Merck & Co., Inc.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      9. Norbrook
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      10. Purina Animal Nutrition LLC.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      11. Kyoritsuseiyaku Corporation
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      12. Equine Products UK Ltd.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Statistics: Equine Population, By Key Countries, 2024
    2. Regulatory Scenario, Equine Health, By Key Countries, 2024
    3. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, etc.)
    4. Technology Advances in Equine Health
    5. Impact of Covid-19 on the Market
  5. Global Equine Health Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product
      1. Drug Type
        1. Anti-Infectives
        2. Anti-Inflammatory
        3. Parasiticides
        4. Others
      2. Vaccine Type
        1. Inactivated
        2. Live Attenuated
        3. Recombinant
        4. Others
      3. Supplemental Feed Additives
    2. Market Analysis, Insights and Forecast – By Disease Type
      1. West Nile Virus
      2. Equine Rabies
      3. Equine Influenza
      4. Equine Herpes Virus
      5. Potomac Horse Fever
      6. Tetanus
      7. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Veterinary Hospitals and Clinics
      2. Retail Pharmacies and Drug Stores
      3. Others
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Equine Health Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product
      1. Drug Type
        1. Anti-Infectives
        2. Anti-Inflammatory
        3. Parasiticides
        4. Others
      2. Vaccine Type
        1. Inactivated
        2. Live Attenuated
        3. Recombinant
        4. Others
      3. Supplemental Feed Additives
    2. Market Analysis, Insights and Forecast – By Disease Type
      1. West Nile Virus
      2. Equine Rabies
      3. Equine Influenza
      4. Equine Herpes Virus
      5. Potomac Horse Fever
      6. Tetanus
      7. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Veterinary Hospitals and Clinics
      2. Retail Pharmacies and Drug Stores
      3. Others 
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Equine Health Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product
      1. Drug Type
        1. Anti-Infectives
        2. Anti-Inflammatory
        3. Parasiticides
        4. Others
      2. Vaccine Type
        1. Inactivated
        2. Live Attenuated
        3. Recombinant
        4. Others
      3. Supplemental Feed Additives
    2. Market Analysis, Insights and Forecast – By Disease Type
      1. West Nile Virus
      2. Equine Rabies
      3. Equine Influenza
      4. Equine Herpes Virus
      5. Potomac Horse Fever
      6. Tetanus
      7. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Veterinary Hospitals and Clinics
      2. Retail Pharmacies and Drug Stores
      3. Others 
    4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. U.K.
      2. Germany
      3. France
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Equine Health Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product
      1. Drug Type
        1. Anti-Infectives
        2. Anti-Inflammatory
        3. Parasiticides
        4. Others
      2. Vaccine Type
        1. Inactivated
        2. Live Attenuated
        3. Recombinant
        4. Others
      3. Supplemental Feed Additives
    2. Market Analysis, Insights and Forecast – By Disease Type
      1. West Nile Virus
      2. Equine Rabies
      3. Equine Influenza
      4. Equine Herpes Virus
      5. Potomac Horse Fever
      6. Tetanus
      7. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Veterinary Hospitals and Clinics
      2. Retail Pharmacies and Drug Stores
      3. Others
    4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Equine Health Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product
      1. Drug Type
        1. Anti-Infectives
        2. Anti-Inflammatory
        3. Parasiticides
        4. Others
      2. Vaccine Type
        1. Inactivated
        2. Live Attenuated
        3. Recombinant
        4. Others
      3. Supplemental Feed Additives
    2. Market Analysis, Insights and Forecast – By Disease Type
      1. West Nile Virus
      2. Equine Rabies
      3. Equine Influenza
      4. Equine Herpes Virus
      5. Potomac Horse Fever
      6. Tetanus
      7. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Veterinary Hospitals and Clinics
      2. Retail Pharmacies and Drug Stores
      3. Others
    4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Equine Health Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product
      1. Drug Type
        1. Anti-Infectives
        2. Anti-Inflammatory
        3. Parasiticides
        4. Others
      2. Vaccine Type
        1. Inactivated
        2. Live Attenuated
        3. Recombinant
        4. Others
      3. Supplemental Feed Additives
    2. Market Analysis, Insights and Forecast – By Disease Type
      1. West Nile Virus
      2. Equine Rabies
      3. Equine Influenza
      4. Equine Herpes Virus
      5. Potomac Horse Fever
      6. Tetanus
      7. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Veterinary Hospitals and Clinics
      2. Retail Pharmacies and Drug Stores
      3. Others
    4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. GCC
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2024)
    2. Company Profiles
      1. Zoetis Services LLC
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Ceva
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Elanco
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Boehringer Ingelheim International GmbH
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Vetoquinol
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. Neogen Corporation
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Virbac
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. Merck & Co., Inc.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      9. Norbrook
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      10. Purina Animal Nutrition LLC.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      11. Kyoritsuseiyaku Corporation
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      12. Equine Products UK Ltd.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
Read Less

Figure 01: Global Equine Health Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2032

Figure 02: Global Equine Health Market Value Share (%), By Product, 2025 & 2032

Figure 03: Global Equine Health Market Value Share (%), By Disease Type, 2025 & 2032

Figure 04: Global Equine Health Market Value Share (%), By Distribution Channel, 2025 & 2032

Figure 05: Global Equine Health Market Value Share (%), By Region, 2025 & 2032

Figure 06: North America Equine Health Market Value (USD billion), By Product, 2025 & 2032

Figure 07: North America Equine Health Market Value Share (%), By Product, 2024

Figure 08: North America Equine Health Market Value (USD billion), By Disease Type, 2025 & 2032

Figure 09: North America Equine Health Market Value Share (%), By Disease Type, 2024

Figure 10: North America Equine Health Market Value (USD billion), By Distribution Channel, 2025 & 2032

Figure 11: North America Equine Health Market Value Share (%), By Distribution Channel, 2024

Figure 12: North America Equine Health Market Value (USD billion), By Country, 2025 & 2032

Figure 13: North America Equine Health Market Value Share (%), By Country, 2024

Figure 14: Europe Equine Health Market Value (USD billion), By Product, 2025 & 2032

Figure 15: Europe Equine Health Market Value Share (%), By Product, 2024

Figure 16: Europe Equine Health Market Value (USD billion), By Disease Type, 2025 & 2032

Figure 17: Europe Equine Health Market Value Share (%), By Disease Type, 2024

Figure 18: Europe Equine Health Market Value (USD billion), By Distribution Channel, 2025 & 2032

Figure 19: Europe Equine Health Market Value Share (%), By Distribution Channel, 2024

Figure 20: Europe Equine Health Market Value (USD billion), By Country/ Sub-Region, 2025 & 2032

Figure 21: Europe Equine Health Market Value Share (%), By Country/ Sub-Region, 2024

Figure 22: Asia Pacific Equine Health Market Value (USD billion), By Product, 2025 & 2032

Figure 23: Asia Pacific Equine Health Market Value Share (%), By Product, 2024

Figure 24: Asia Pacific Equine Health Market Value (USD billion), By Disease Type, 2025 & 2032

Figure 25: Asia Pacific Equine Health Market Value Share (%), By Disease Type, 2024

Figure 26: Asia Pacific Equine Health Market Value (USD billion), By Distribution Channel, 2025 & 2032

Figure 27: Asia Pacific Equine Health Market Value Share (%), By Distribution Channel, 2024

Figure 28: Asia Pacific Equine Health Market Value (USD billion), By Country/ Sub-Region, 2025 & 2032

Figure 29: Asia Pacific Equine Health Market Value Share (%), By Country/ Sub-Region, 2024

Figure 30: Latin America Equine Health Market Value (USD billion), By Product, 2025 & 2032

Figure 31: Latin America Equine Health Market Value Share (%), By Product, 2024

Figure 32: Latin America Equine Health Market Value (USD billion), By Disease Type, 2025 & 2032

Figure 33: Latin America Equine Health Market Value Share (%), By Disease Type, 2024

Figure 34: Latin America Equine Health Market Value (USD billion), By Distribution Channel, 2025 & 2032

Figure 35: Latin America Equine Health Market Value Share (%), By Distribution Channel, 2024

Figure 36: Latin America Equine Health Market Value (USD billion), By Country/ Sub-Region, 2025 & 2032

Figure 37: Latin America Equine Health Market Value Share (%), By Country/ Sub-Region, 2024

Figure 38: Middle East & Africa Equine Health Market Value (USD billion), By Product, 2025 & 2032

Figure 39: Middle East & Africa Equine Health Market Value Share (%), By Product, 2024

Figure 40: Middle East & Africa Equine Health Market Value (USD billion), By Disease Type, 2025 & 2032

Figure 41: Middle East & Africa Equine Health Market Value Share (%), By Disease Type, 2024

Figure 42: Middle East & Africa Equine Health Market Value (USD billion), By Distribution Channel, 2025 & 2032

Figure 43: Middle East & Africa Equine Health Market Value Share (%), By Distribution Channel, 2024

Figure 44: Middle East & Africa Equine Health Market Value (USD billion), By Country/ Sub-Region, 2025 & 2032

Figure 45: Middle East & Africa Equine Health Market Value Share (%), By Country/ Sub-Region, 2024

Figure 46: The figure besides highlights the market share (%) of companies operating in the global equine health market, 2024.

Table 01: Global Equine Health Market Revenue (USD billion) Forecast, By Product, 2019–2032

Table 02: Global Equine Health Market Revenue (USD billion) Forecast, By Drug Type, 2019–2032

Table 03: Global Equine Health Market Revenue (USD billion) Forecast, By Vaccine Type, 2019–2032

Table 04: Global Equine Health Market Revenue (USD billion) Forecast, By Disease Type, 2019–2032

Table 05: Global Equine Health Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 06: Global Equine Health Market Revenue (USD billion) Forecast, By Region, 2019–2032

Table 07: North America Equine Health Market Revenue (USD billion) Forecast, By Product, 2019–2032

Table 08: North America Equine Health Market Revenue (USD billion) Forecast, By Drug Type, 2019–2032

Table 09: North America Equine Health Market Revenue (USD billion) Forecast, By Vaccine Type, 2019–2032

Table 10: North America Equine Health Market Revenue (USD billion) Forecast, By Disease Type, 2019–2032

Table 11: North America Equine Health Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 12: North America Equine Health Market Revenue (USD billion) Forecast, By Country, 2019–2032

Table 13: Europe Equine Health Market Revenue (USD billion) Forecast, By Product, 2019–2032

Table 14: Europe Equine Health Market Revenue (USD billion) Forecast, By Drug Type, 2019–2032

Table 15: Europe Equine Health Market Revenue (USD billion) Forecast, By Vaccine Type, 2019–2032

Table 16: Europe Equine Health Market Revenue (USD billion) Forecast, By Disease Type, 2019–2032

Table 17: Europe Equine Health Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 18: Europe Equine Health Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2019–2032

Table 19: Asia Pacific Equine Health Market Revenue (USD billion) Forecast, By Product, 2019–2032

Table 20: Asia Pacific Equine Health Market Revenue (USD billion) Forecast, By Drug Type, 2019–2032

Table 21: Asia Pacific Equine Health Market Revenue (USD billion) Forecast, By Vaccine Type, 2019–2032

Table 22: Asia Pacific Equine Health Market Revenue (USD billion) Forecast, By Disease Type, 2019–2032

Table 23: Asia Pacific Equine Health Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 24: Asia Pacific Equine Health Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2019–2032

Table 25: Latin America Equine Health Market Revenue (USD billion) Forecast, By Product, 2019–2032

Table 26: Latin America Equine Health Market Revenue (USD billion) Forecast, By Drug Type, 2019–2032

Table 27: Latin America Equine Health Market Revenue (USD billion) Forecast, By Vaccine Type, 2019–2032

Table 28: Latin America Equine Health Market Revenue (USD billion) Forecast, By Disease Type, 2019–2032

Table 29: Latin America Equine Health Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 30: Latin America Equine Health Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2019–2032

Table 31: Middle East & Africa Equine Health Market Revenue (USD billion) Forecast, By Product, 2019–2032

Table 32: Middle East & Africa Equine Health Market Revenue (USD billion) Forecast, By Drug Type, 2019–2032

Table 33: Middle East & Africa Equine Health Market Revenue (USD billion) Forecast, By Vaccine Type, 2019–2032

Table 34: Sweden Equine Health Market Revenue (USD billion) Forecast, By Disease Type, 2019–2032

Table 35: Middle East & Africa Equine Health Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 36: Middle East & Africa Equine Health Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2019–2032

  • 2019-2032
  • 2024
  • 2019-2023
  • 164
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann